Palbociclib Combined with an Aromatase Inhibitor in Patients with Breast Cancer with Lung or Liver Metastases in US Clinical Practice.

MLA

Brufsky, Adam, et al. “Palbociclib Combined with an Aromatase Inhibitor in Patients with Breast Cancer with Lung or Liver Metastases in US Clinical Practice.” Cancers, vol. 15, no. 21, Nov. 2023, p. 5268. EBSCOhost, https://doi.org/10.3390/cancers15215268.

APA

Brufsky, A., Liu, X., Li, B., McRoy, L., Chen, C., Layman, R. M., & Rugo, H. S. (2023). Palbociclib Combined with an Aromatase Inhibitor in Patients with Breast Cancer with Lung or Liver Metastases in US Clinical Practice. Cancers, 15(21), 5268. https://doi.org/10.3390/cancers15215268

Chicago

Brufsky, Adam, Xianchen Liu, Benjamin Li, Lynn McRoy, Connie Chen, Rachel M. Layman, and Hope S. Rugo. 2023. “Palbociclib Combined with an Aromatase Inhibitor in Patients with Breast Cancer with Lung or Liver Metastases in US Clinical Practice.” Cancers 15 (21): 5268. doi:10.3390/cancers15215268.